The added value of PSMA PET to nomograms in identifying optimal candidates for extended pelvic lymph node dissection in intermediate-risk prostate cancer patients

Our findings suggest that integrating PSMA PET with nomograms in intermediate-risk cases could optimize patient selection for ePLND, potentially reducing unnecessary surgeries without increasing the risk of missed LNI cases. Preoperative staging with PSMA PET may play both exclusive and inclusive roles in the intermediate-risk setting. If PSMA PET shows N0, it may exclude candidates from ePLND. Additionally, when combined with nomograms, it may help select candidates for ePLND among patients who show a high risk of LNI according to risk calculators.

Authors

Institutions

Publication Details

Journal
Minerva Urology and Nephrology
Published
2025-10-01
DOI
https://doi.org/10.23736/s2724-6051.25.06470-5
Citations
1
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The added value of PSMA PET to nomograms in identifying optimal candidates for extended pelvic lymph node dissection in intermediate-risk prostate cancer patients

Daniele Robesti, Cristian Fiori, Pasquale Rescigno, Francesco Barletta et al.
1 citations
Minerva Urology and Nephrology
Prostate Cancer Diagnosis and Treatment
1.52
article

The added value of PSMA PET to nomograms in identifying optimal candidates for extended pelvic lymph node dissection in intermediate-risk prostate cancer patients

Daniele Robesti, Cristian Fiori, Pasquale Rescigno, Francesco Barletta, Gianmario Sambuceti, Michele Ortenzi, Enrico Checcucci, Alberto Briganti, Carlo Terrone, Matteo Bauckneht, Francesco Lanfranchi, Sabrina De Cillis, Daniele Amparore, Giorgio Gandaglia, A. Sterrantino, Simone Scuderi, F. Porpiglia, Arturo Chiti, Edoardo Cisero, Stefano De Luca, Alessio Rizzo, Alessio Signori, Valentina Pau
article en
1 citations

Abstract

Our findings suggest that integrating PSMA PET with nomograms in intermediate-risk cases could optimize patient selection for ePLND, potentially reducing unnecessary surgeries without increasing the risk of missed LNI cases. Preoperative staging with PSMA PET may play both exclusive and inclusive roles in the intermediate-risk setting. If PSMA PET shows N0, it may exclude candidates from ePLND. Additionally, when combined with nomograms, it may help select candidates for ePLND among patients who show a high risk of LNI according to risk calculators.

Minerva Urology and NephrologyVol. 77(5)
Vita-Salute San Raffaele University (IT), Ospedale Policlinico San Martino (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Ospedale San Luigi Gonzaga (IT), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT), University of Turin (IT), University of Genoa (IT), Newcastle University (GB)
Openalex Percentile: Top 13%
Prostate Cancer Diagnosis and Treatment
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.